Pro Share Advisors LLC Oncocyte Corp Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.86 - $1.53 $17,909 - $31,862	-20,825 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$1.15 - $2.25 $6,107 - $11,949	-5,311 Reduced 20.32%	20,825 $31,000
Q4 2021 Feb 08, 2022	BUY	$2.04 - $3.59 $53,317 - $93,828	26,136 New	26,136 $56,000
Q3 2021 Nov 12, 2021	SELL	$3.53 - $5.89 $64,891 - $108,275	-18,383 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$3.77 - $6.0 $2,507 - $3,990	-665 Reduced 3.49%	18,383 $106,000
Q1 2021 May 14, 2021	BUY	$2.39 - $6.5 $12,217 - $33,228	5,112 Added 36.68%	19,048 $99,000
Q4 2020 Feb 09, 2021	BUY	$1.38 - $2.63 $19,231 - $36,651	13,936 New	13,936 $33,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $259M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.